Stem cell therapies, especially those based on induced pluripotent stem cells (iPSCs), hold immense potential in revolutionizing regenerative medicine, personalized treatments, and disease modeling. These therapies offer a unique avenue to address previously challenging health conditions and have sparked significant interest in the scientific and medical communities. However, the development and application of iPSC-based treatments […]
Category: iPSC
Advancements in Off-the-Shelf iPSC-Derived Cell Therapies
In an exciting turn of events in the biotech industry, Fate Therapeutics, a leading biopharmaceutical company, is set to grace the EULAR 2025 Congress in Barcelona, Spain with a detailed presentation of their clinical and preclinical data. This will cast a spotlight on their groundbreaking off-the-shelf cell therapy platform, which is centered around induced pluripotent […]

